Textile-Based Delivery is a technology company.
Textile-Based Delivery has raised $2.6M across 2 funding rounds.
Textile-Based Delivery has raised $2.6M in total across 2 funding rounds.
Textile-Based Delivery has raised $2.6M in total across 2 funding rounds.
Textile-Based Delivery's investors include Keiretsu Capital.
Textile-Based Delivery is a Seattle-based technology company specializing in smart textiles that deliver active ingredients like medicines, vitamins, and supplements through clothing for health and wellness benefits.[1][2][5] It builds Clothing 2.0 (C2), a platform infusing consistent doses of OTC and cosmetic ingredients into yarns to create reusable, laundry-safe HealthWear garments that activate upon skin contact, providing controlled dermal and transdermal relief.[1][2] The company serves partners in health, wellness, apparel, drug delivery, and textile sectors, solving the problem of convenient, non-invasive drug delivery by embedding therapeutics directly into everyday apparel, bypassing traditional pills or creams.[2][5] After selling its successful Nufabrx retail brand, it has pivoted to B2B partnerships, with over one million partner products sold across 15,000 retail locations, demonstrating strong growth momentum.[1][2]
Founded by Jordan Schindler, CEO with expertise in science, textiles, and regulations, Textile-Based Delivery emerged from innovations in microencapsulated actives embedded in stylish fabrics for therapeutic release.[1][2][3] The idea stemmed from developing proprietary "smart fabrics" that deliver health benefits through skin contact, initially commercialized via the Nufabrx retail line of medicated apparel.[1][2] A pivotal moment came in September 2023 with the sale of Nufabrx to Tallayne Holdings after its market success, enabling the launch of Clothing 2.0 to focus on partnerships; the company raised $350K about 10 years prior and operates from facilities including a 20,000 sq. ft. USA clean room.[1][2]
Textile-Based Delivery rides the wearable health tech and personalized medicine trends, merging textiles with drug delivery amid rising demand for non-pharmaceutical, convenient wellness solutions.[2] Timing aligns with post-pandemic focus on at-home health management and sustainable, reusable alternatives to disposables, bolstered by market forces like aging populations and OTC supplement growth.[1][2] It influences the ecosystem by enabling apparel brands and health firms to innovate via its platform, expanding smart-textile adoption beyond fitness trackers into therapeutic garments and fostering cross-sector collaborations in drug-textile integration.[2]
Textile-Based Delivery is poised to scale its Clothing 2.0 platform globally through more selective partnerships, leveraging its proven track record to penetrate emerging markets in wellness wearables and personalized therapeutics.[2] Trends like AI-optimized ingredient delivery and sustainable biotech textiles will shape its path, potentially amplifying influence as HealthWear becomes mainstream for chronic pain relief and daily supplementation.[1][2] With its pivot from retail to B2B, expect expanded retail footprints and new collaborations, solidifying its role as a pioneer in textile-based drug delivery and returning to the innovative apparel that first disrupted healthcare.
Textile-Based Delivery has raised $2.6M across 2 funding rounds. Most recently, it raised $580K Venture Round in December 2017.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 1, 2017 | $580K Venture Round | Keiretsu Capital | |
| Sep 1, 2016 | $2.0M Seed | Keiretsu Capital |